NCT05681234View on ClinicalTrials.gov

Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma

NACompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

August 24, 2022

Primary Completion Date

November 2, 2022

Study Completion Date

December 20, 2022

Conditions

Liver Carcinoma

Interventions

RADIATION

18F-RD2

Patients will receive 5-10 mCi 18F-RD2

Trial Locations (1)

214000

Affiliated Hospital of Jiangnan University, Wuxi

All Listed Sponsors

lead

Affiliated Hospital of Jiangnan University

OTHER